Silvant Capital Management LLC lessened its position in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 87.7% during the 1st quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 535 shares of the company's stock after selling 3,807 shares during the quarter. Silvant Capital Management LLC's holdings in Docusign were worth $44,000 at the end of the most recent quarter.
Several other hedge funds have also recently added to or reduced their stakes in the stock. Ieq Capital LLC lifted its stake in Docusign by 1.5% in the first quarter. Ieq Capital LLC now owns 16,066 shares of the company's stock valued at $1,308,000 after buying an additional 238 shares during the period. WCG Wealth Advisors LLC acquired a new position in Docusign in the first quarter valued at about $816,000. Kayne Anderson Rudnick Investment Management LLC lifted its stake in Docusign by 427.8% in the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 950 shares of the company's stock valued at $77,000 after buying an additional 770 shares during the period. Freedom Investment Management Inc. lifted its stake in Docusign by 170.0% in the first quarter. Freedom Investment Management Inc. now owns 8,203 shares of the company's stock valued at $668,000 after buying an additional 5,165 shares during the period. Finally, Oak Harvest Investment Services lifted its stake in Docusign by 28.3% in the first quarter. Oak Harvest Investment Services now owns 24,076 shares of the company's stock valued at $1,960,000 after buying an additional 5,306 shares during the period. Institutional investors and hedge funds own 77.64% of the company's stock.
Docusign Price Performance
Shares of Docusign stock traded up $1.15 during trading hours on Friday, hitting $76.66. The company's stock had a trading volume of 2,272,539 shares, compared to its average volume of 2,302,764. Docusign Inc. has a 12 month low of $54.31 and a 12 month high of $107.86. The stock has a 50 day moving average of $75.41 and a 200 day moving average of $79.73. The company has a market capitalization of $15.49 billion, a PE ratio of 14.49, a price-to-earnings-growth ratio of 28.61 and a beta of 1.01.
Docusign (NASDAQ:DOCU - Get Free Report) last announced its quarterly earnings results on Thursday, June 5th. The company reported $0.90 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.81 by $0.09. The company had revenue of $763.65 million during the quarter, compared to the consensus estimate of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The company's revenue for the quarter was up 7.6% compared to the same quarter last year. During the same period in the prior year, the company earned $0.82 earnings per share. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Equities analysts expect that Docusign Inc. will post 1.17 EPS for the current year.
Docusign declared that its board has initiated a share buyback program on Thursday, June 5th that permits the company to buyback $1.00 billion in shares. This buyback authorization permits the company to repurchase up to 6.6% of its stock through open market purchases. Stock buyback programs are typically an indication that the company's board believes its shares are undervalued.
Analyst Upgrades and Downgrades
DOCU has been the topic of several analyst reports. Wedbush cut their target price on Docusign from $100.00 to $85.00 and set a "neutral" rating on the stock in a research note on Thursday, June 12th. Needham & Company LLC reissued a "hold" rating on shares of Docusign in a research note on Friday, June 6th. Bank of America cut their target price on Docusign from $88.00 to $85.00 and set a "neutral" rating on the stock in a research note on Friday, June 6th. Wall Street Zen downgraded Docusign from a "buy" rating to a "hold" rating in a report on Saturday, August 2nd. Finally, Wells Fargo & Company upgraded Docusign from an "underweight" rating to an "equal weight" rating and increased their price target for the stock from $67.00 to $80.00 in a report on Friday, June 13th. Four research analysts have rated the stock with a Buy rating and twelve have issued a Hold rating to the stock. According to data from MarketBeat, the company currently has a consensus rating of "Hold" and a consensus target price of $89.77.
View Our Latest Analysis on DOCU
Insider Transactions at Docusign
In related news, CEO Allan C. Thygesen sold 40,000 shares of the stock in a transaction dated Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the completion of the transaction, the chief executive officer directly owned 143,983 shares in the company, valued at approximately $11,160,122.33. This trade represents a 21.74% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Robert Chatwani sold 22,875 shares of the stock in a transaction dated Wednesday, June 18th. The stock was sold at an average price of $74.79, for a total value of $1,710,821.25. Following the transaction, the insider owned 72,126 shares of the company's stock, valued at approximately $5,394,303.54. The trade was a 24.08% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 78,552 shares of company stock valued at $5,983,631 in the last ninety days. Corporate insiders own 1.01% of the company's stock.
About Docusign
(
Free Report)
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Articles
Before you consider Docusign, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Docusign wasn't on the list.
While Docusign currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
